AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best stocks under $5 with huge upside potential. On April 9, ...

Investors in AbCellera Biologics Inc (Symbol: ABCL) saw new options become available this week, for the November 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and ...

Recent discussions on X about AbCellera Biologics (ABCL) have been buzzing with excitement following a significant surge in the stock price, with some posts noting a jump of over 25% in a single day.

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best strong buy stocks to invest in under $5. AbCellera Biologics Inc. (NASDAQ:ABCL) announced on January 22 that it is set to announce its ...

Image source: The Motley Fool. Strategic investments advanced AbCellera Biologics(NASDAQ:ABCL) from a platform to a clinical-stage company, highlighted by the initiation of two first-in-human studies ...

AbCellera Biologics Inc. (NASDAQ:ABCL) ranks among the stocks that could 10x over the next 5 years. On March 17, AbCellera Biologics Inc. (NASDAQ:ABCL) outlined its vision at the KeyBanc Capital ...

Vancouver-based biotech firm AbCellera Biologics Inc. (NASDAQ:ABCL) has announced a major milestone in its fight against atopic dermatitis (AD). The company has secured a No Objection Letter from ...

Dr. Hansen explained that "the main scientific risk for ABCL-635 is whether or not we can achieve sufficient target engagement," with proof-of-concept data expected to provide clarity in mid-2026.